疟疾诊断市场规模、份额和成长分析（按产品、技术、最终用途和地区）- 产业预测（2025-2032 年）

2023 年全球疟疾诊断市场规模为 8.4451 亿美元，预计将从 2024 年的 8.842 亿美元增长到 2032 年的 12.7681 亿美元，预测期内（2025-2032 年）的复合年增长率为 4.7%。

受分子诊断和快速诊断测试 (RDT) 等诊断技术的进步推动，全球疟疾诊断市场正在经历显着成长。这些创新提高了敏感性、特异性和易用性，从而能够快速诊断，特别是在资源有限的地区。人们对早期发现疟疾的认识不断提高，再加上政府措施和全球基金等组织的支持，进一步推动了市场的扩张。但挑战依然存在，包括偏远地区卫生基础设施不足，以及对低收入国家检测的可负担性和可近性的担忧。此外，一些测试的准确性问题和监管障碍也可能限製成长。为了有效对抗疟疾，公私合作对于开发经济实惠、可靠且适合当地文化的诊断解决方案至关重要。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

疟疾诊断市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 装置
• 套件和试剂

疟疾诊断市场规模（依技术及复合年增长率） (2025-2032)

• 市场概况
• 显微镜
• 快速诊断测试
• 分子诊断检测
  • 常规 PCR
  • 即时PCR
• 其他技术

疟疾诊断市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概况
• 诊所
• 医院
• 诊断中心
• 其他的

疟疾诊断市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• 雅培实验室（美国）
• Bio-Rad Laboratories, Inc.（美国）
• 西门子医疗股份公司（德国）
• 赛默飞世尔科技公司（美国）
• F. Hoffmann-La Roche Ltd（瑞士）
• 生物梅里埃公司（法国）
• 贝克曼库尔特公司（美国）
• Cepheid Inc.（美国）
• 丹纳赫集团（美国）
• Hologic 公司（美国）
• Illumina公司（美国）
• Qiagen NV（荷兰）
• Sysmex 公司 (日本)
• 尼康公司（日本）
• 奥林巴斯株式会社（日本）
• DiaSorin SpA（义大利）
• Trinity Biotech plc（爱尔兰）
• 富士软片株式会社（日本）

结论和建议

Global Malaria Diagnostics Market size was valued at USD 844.51 million in 2023 and is poised to grow from USD 884.2 million in 2024 to USD 1276.81 million by 2032, growing at a CAGR of 4.7% during the forecast period (2025-2032).

The global malaria diagnostics market has experienced significant growth, propelled by advancements in diagnostic technologies like molecular diagnostics and rapid diagnostic tests (RDTs). These innovations have enhanced sensitivity, specificity, and user-friendliness, enabling quicker diagnoses, particularly in resource-limited areas. Increasing awareness of early malaria detection, coupled with government initiatives and support from organizations like the Global Fund, has further stimulated market expansion. However, challenges persist, including inadequate healthcare infrastructure in remote regions, as well as concerns about the affordability and accessibility of tests in low-income countries. Additionally, issues regarding the accuracy of some tests and regulatory obstacles may limit growth. Collaborative efforts from public and private sectors are essential to develop affordable, reliable, and culturally appropriate diagnostic solutions to combat malaria effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Malaria Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Malaria Diagnostics Market Segments Analysis

Global Malaria Diagnostics Market is segmented by Product, Technology, End-use and Region. Based on Product, the market is segmented into Instruments and Kits & reagents. Based on Technology, the market is segmented into Microscopy, Rapid diagnostic tests, Molecular diagnostic tests and Other technologies. Based on End-use, the market is segmented into Clinics, Hospitals, Diagnostic centers and Other end-users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Malaria Diagnostics Market

The Global Malaria Diagnostics market is significantly influenced by regions heavily impacted by malaria, especially in sub-Saharan Africa and certain areas of Asia. In these regions, there is a strong demand for effective malaria diagnostics driven by the critical need for accurate and prompt diagnosis. Timely identification of malaria cases is essential for the effective management and control of the disease, making malaria diagnostics an indispensable part of public health efforts. As the burden of malaria remains high, the focus on developing and implementing reliable diagnostic tools will continue to be a major driver for the market's growth and evolution.

Restraints in the Global Malaria Diagnostics Market

The global malaria diagnostics market faces significant restraints due to inadequate investment in research and development. This shortfall restricts the emergence of innovative and advanced diagnostic technologies, as there is insufficient funding for research initiatives aimed at creating tests that are more sensitive, specific, and cost-effective. Consequently, the lack of financial support hampers progress in developing better diagnostic solutions, potentially stalling efforts to enhance malaria detection and management. Without increased investment in R&D, the market may struggle to keep pace with the evolving needs for effective malaria diagnostics, ultimately impacting control and prevention strategies globally.

Market Trends of the Global Malaria Diagnostics Market

The Global Malaria Diagnostics market is witnessing significant growth, particularly driven by expansion into emerging markets across Asia, Latin America, and Africa. As healthcare expenditures rise alongside heightened awareness of infectious diseases, these regions are becoming hotspots for diagnostic innovation. Government initiatives aimed at combating malaria further bolster this trend, creating a favorable environment for diagnostic companies. To effectively tap into these burgeoning markets, businesses are focusing on developing cost-effective and culturally sensitive diagnostic solutions that cater to local needs, ultimately enhancing accessibility and improving health outcomes in malaria-endemic regions. This strategic focus is poised to accelerate market growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Malaria Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Kits & reagents

Global Malaria Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Microscopy
• Rapid diagnostic tests
• Molecular diagnostic tests
  • Conventional PCR
  • Real-time PCR
• Other technologies

Global Malaria Diagnostics Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Clinics
• Hospitals
• Diagnostic centers
• Other end-users

Global Malaria Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Technology, End-use)
  • US
  • Canada
• Europe (Product, Technology, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen NV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikon Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FujiFilm Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations